TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
NVO

Novo Nordisk A/S

Healthcare · Drug Manufacturers - General

38.80$ +0.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Novo Nordisk A/S (NVO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 309,064 million DKK. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size % Per share
Last 12 Full history
Download as CSV

All figures in millions of DKK.

Tick rows to compare them in a chart (up to 4)

Income Statement NVO
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
88,806 107,927 111,780 111,696 111,831 122,021 126,946 140,800 176,954 232,261 290,403 309,064
14,562 16,188 17,183 17,632 17,617 20,088 20,932 23,658 28,448 35,765 44,522 58,788
74,244 91,739 94,597 94,064 94,214 101,933 106,014 117,142 148,506 196,496 245,881 250,276
13,762 13,608 14,563 14,014 14,805 14,220 15,462 17,772 24,047 32,443 48,062 52,039
3,537 3,857 3,962 3,784 3,916 4,007 3,958 4,050 4,467 4,855 5,276 5,969
39,752 42,295 46,165 45,097 46,966 49,450 51,888 58,498 73,697 93,922 117,542 122,618
34,492 49,444 48,432 48,967 47,248 52,483 54,126 58,644 74,809 102,574 128,339 127,658
39 67 65 90 85 220 390 289 378 542 1,640 4,207
34,096 43,483 47,798 48,680 47,615 48,553 53,130 59,080 69,062 104,674 127,191 130,540
7,615 8,623 9,873 10,550 8,987 9,602 10,992 11,323 13,537 20,991 26,203 28,106
26,481 34,860 37,925 38,130 38,628 38,951 42,138 47,757 55,525 83,683 100,988 102,434
37,570 46,509 51,056 51,952 51,625 54,434 59,273 65,394 76,802 114,629 147,938 156,729

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?